interestingly, PARP1 agonists such as β-lapachone and deoxypodophyllotoxin are reported to trigger parthanatos in hepatoma carcinoma cells and glioma cells through indirectly activating PARP1 via induction of excessive ROS. Here, PARP1 is linked to central nervous system cancer.